Common Stock SEC Reporting - Current
Verified Company Profile 5/16/2017
Contact Info
  • 126 Valley Road
  • Suite C
  • Glen Rock, NJ 07452

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000849636
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1987
Employees 4 a/o Nov 02, 2015
Company Officers/Contacts
James S. J. Manuso President, CEO
Jeff E. Margolis Secretary, Vice President, Interim CFO
Richard D. Purcell, Jr. SVP, R&D
Arnold S. Lippa CSO
Company Directors
Arnold S. Lippa Chairman
Kathryn MacFarlane
James S. J. Manuso
Jeff E. Margolis
James Sapirstein
Service Providers
Accounting/Auditing Firm
Haskell & White LLP
300 Spectrum Drive
Suite 300
Irvine, CA, 92618
United States
Securities Counsel
Drinker Biddle
600 Campus Dr.
Florham Park, NJ, 07932-1047
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Cortex Pharmaceuticals, Inc. until 1-2016
RSPI Security Details
Share Structure
Market Value1 $4,005,829 a/o Oct 20, 2017
Authorized Shares 65,000,000 a/o Sep 30, 2016
Outstanding Shares 2,289,045 a/o May 17, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders of Record 449 a/o Mar 31, 2017
Short Selling Data
Short Interest 3,098 (0%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security